Physician profile

Eric Auerbach

Cardiovascular Disease · Tulsa, OK

NPI 1881664399

$34,999.33

in general payments reported to CMS, 2019-2025

16 companies · $254 in 2025

The $254 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$633.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $20,387.76 2019-2020
Amgen INC. $13,848.40 2019-2025 Repatha, Repatha
Pfizer INC. $293.52 2019-2024
Abiomed $207.26 2024-2025 Impella
Novo Nordisk INC $64.54 2021
Heartflow, INC. $43.77 2021
E.R. Squibb & Sons, L.L.C. $43.34 2024-2025 Camzyos, Eliquis
Irhythm Technologies, INC. $19.86 2023 Zio Xt Patch
Boston Scientific Corporation $18.23 2025 Watchman Flx
Surmodics, INC. $15.86 2023 Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter
Abbott Laboratories $15.66 2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $14.62 2019
Alexion Pharmaceuticals, INC. $13.79 2019
Janssen Pharmaceuticals, INC $12.72 2023 Xarelto

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric Auerbach

$34,999.33

in general payments reported 2019-2025

Years
2019-2025
Top company
Amarin Pharma, INC.
Context
The $254 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/266419/eric-auerbach

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.